5HT drugs in animal models of anxiety

Psychopharmacology

Volumn 112, Issue 1, 1993, Pages 13-20

  Handley, S L ^a   McBlane, J W ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

5HT; Animal model; Anxiety

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ANXIOLYTIC AGENT; BUSPIRONE; FLUOXETINE; GEPIRONE; IPSAPIRONE; KETANSERIN; ONDANSETRON; RECEPTOR SUBTYPE; RITANSERIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; SEROTONIN UPTAKE INHIBITOR;

ANIMAL MODEL; ANXIETY NEUROSIS; BEHAVIOR; DEPRESSION; HUMAN; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM;

ANIMAL; ANXIETY; DISEASE MODELS, ANIMAL; HUMAN; SEROTONIN AGENTS;

EID: 0027250855     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02247358     Document Type: Review

References (100)

1. Decreased reactivity to anxiolytics caused by early protein malnutrition in rats
2. Microinjection of propranolol into the dorsal periaqueductal gray causes an anxiolytic effect in the elevated plus maze antagonised by ritanserin
3. Attenuation of a chemically induced defence response by 5HT1 receptor agonists administered into the periaqueductal grey
4. Electrophysiological investigation of the adaptive response of the 5-HT system to the administration of 5-HT1A receptor agoinists
5. Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons
6. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
7. The influence of ritanserin, a serotonin receptor antagonist, in anxiety disorders: a double blind placebo-controlled study versus lorazepam
8. Effect of intravenous l-tryptophan on prolactin and growth hormone and mood in healthy subjects
9. Serotonin functions in anxiety II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects
10. Animal models of anxiety: the effect of compounds that modify serotonergic function
11. Neuroanatomical sites of action of 5-HT3 receptor agonists and antagonists for alteration of aversive behaviour in the mouse
12. Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors
13. Actions and some interactions of some 5-HT1A ligand in the elevated X-maze and effects of dorsal raphe lesions
14. Roles of serotonergic systems in escape, avoidance and other behaviours
15. 5-HT and mechanisms of defence
16. Effects of antidepressant treatments on 5-HT neurotransmission
17. Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin
18. Putative anxiolytics 8-OHDPAT buspirone and TVXQ 7821 are agonists at 5-HT1A autoreceptors in the raphe nuclei
19. Serotonergic mechanisms in the behavioural effects of buspirone and gepirone
20. Anticonflict effects of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT)
21. Inhibition of serotonin synthesis by p-chlorophenylalanine in carcinoid syndrome
22. Can social interaction be used to measure anxiety?
23. Lack of effects of 5-HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat
24. Recent developments in 5-HT-related pharmacology of animal models of anxiety
25. Pharmacological characterization of a modified social interactin model of anxiety in the rat
26. Buspirone: action on serotonin receptors in calf hippocampus
27. Animal models of aversion
28. Tryptaminergic mechanisms in punished and nonpunished behaviour
29. Effect of metergoline on human anxiety
30. Benzodiazepine abuse
31. Benzodiazepines putative anxiolyitics and animal models of anxiety
32. Serotonin in animal models of anxiety: the importance of stimulus and response
33. 5-HT — the disengaging transmitter?
34. Effects of α2-adrenoceptor agonists and antagonists in a maze exploration model of fear-motivated behaviour
35. The effects of ritanserin on aversive classical conditioning in humans
36. Behavioural and biochemical consequences following activation of 5-HT1-like and GABA receptors in the dorsal raphe nucleus of the rat
37. Evidence that the amygdala is involved in the disinhibitory effects of 5HT3-receptors antagonists
38. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination
39. 5-HT receptors: subtypes and second messengers
40. 5-HT and anxiety
41. Opposite control mediated by central 5-HT1A and non-5-HT1A(5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion
42. 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats
43. Anti-depressant-like actions of 5-HT1A agonists and conventional antidepressants in an animal model of depression
44. Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists
45. Monoaminergic mechanisms in aversive brain stimulation
46. Effects of 8-OH-DPAT and buspirone in a passive avoidance test and in the elevated X-maze test in rats
47. Intra-hippocampal buspirone in animal models of anxiety
48. Modulation of baseline behaviour in rats by putative serotonergic agents in three ethoexperimental paradigms
49. Ethologically-based animal models of anxiety disorders
50. The involvement of serotonin in psychiatric disorders and behaviour
51. Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands
52. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists
53. An evaluation of the elevated plus-maze test using a novel anxiolytic buspirone
54. Characterisation of MDL 7300EF as a 5-HT1A selective ligand and its effects in animal models of anxiety; comparison with buspirone 8-OH-DPAT and diazepam
55. Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze
56. The piperazine serotonin (5-HT) agonists m-chlorophenylpiperazine (mCPP) and 6-chloro-2(1-piperzinyl)pyrazine (MK 212) impair avoidance responding in a discrete trial conditioned avoidance procedure
57. Review of the side effect profile of buspirone
58. Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective
59. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
60. Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes and interactions with yohimbine and FG7142 using the elevated plus-maze test in the rat
61. Selective interaction of novel anxiolytics with-5-hydroxytryptamine 1A receptors
62. The effects of p-chlorophenylalanine on experimentally induced conflict in the rat
63. Serotonergic anxiolytics: a review of their clinical efficacy
64. The relative efficacy of buspirone, imipramine and placebo in panic disorder: a preliminary report
65. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test
66. Serotonin and behaviour, with special regard to animal models of anxiety, depression and waiting ability
67. Antianxiety actions of benzodiazepines: decrease in activity of serotonin neurones in the punishment system
68. The effects of p-chlorophenylalanine, a serotonin depletor on avoidance aquisition, pain sensitivity and related behaviour in the rat
69. Are serotonergic neurones involved in the control of anxiety and in the anxiolytic activity of benzodiazepines
70. The involvement of nigral serotonin innervation in the control of punishment-indiced behavioural inhibition in rats
71. Benzodiazepines reduce the tolerance to reward delay in rats
72. Release of suppressed behaviour of rat on the elevated X-maze by 5-HT3 antagonists injected into the basolateral amygdala
73. 5-HT1A receptor-related anxiolytics
74. The effects of benzodiazepine and serotonergic manipulations on punished responding
75. Inhibition of serotonergic dorsal raphe neurones by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug
76. The concept of selectivity in 5-HT receptor research
77. Effect of diazepam in rats placed on the elevated T-maze, a possible experimental model of anxiety and memory
78. Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus
79. Serotonergic modulation of the rat pup ultrasonic isolation call test; studies with 5-HT1 and 5-HT2 subtype selective agonists and antagonists
80. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze